Reperfusion Injury |
ACTRN12613000031763: Statin Therapy in Ischemia-Reperfusion Injury during coronary artery bypass grafting. |
|
|
| Not yet recruiting | 4 | 100 | | | South Australian Health and Medical Research Institute, South Australian Health and Medical Research Institute | Post CABG ischemia reperfusion injury (IRI) | | | | |
ChiCTR2000040629: Effect of dexmedetomidine on liver postoperative function following living donor hepatectomy |
|
|
| Recruiting | 4 | 56 | | dexmedetomidine ;normal saline | Beijing Friendship Hospital, Capital Medical University; Beijing Friendship Hospital, Capital Medical University, Self-raised | Hepatic ischemia-reperfusion injury | | | | |
ChiCTR-TRC-09000422: The protective effect of βblocker (esmolol) on myocardial ischemia-reperfusion injury during open heart surgery in children |
|
|
| Completed | 4 | 28 | | No esmolol infusion during CPB ;Esmolol was given via peripheral vein by continuous application (0.05mg/kg/min after intubation, 0.3 mg/kg/min during the extracorporeal circuit and 0.03-0.05mg/kg/min after weaning from bypass) | Department of Anesthesiology, Union Hospital, Wuhan City, Hubei Province, China; Level of the institution:, Self-funding | Ventricular septal defect | | | | |
ChiCTR-TRC-11001473: The effect of Ulinastatin on the inflammation response, pain, functional recovery after lower extremity ischemia-reperfusion injury |
|
|
| Completed | 4 | 40 | | Tianpuluoan, Ulinastatin, 10000u/kg, iv. after induction ;Same volume of normal saline, iv, after induction. | Peking Union Medical University Hospital; Techpool Bio-Pharma Co., LTD, Techpool Bio-Pharma Co., LTD. | total knee replacement | | | | |
| Ongoing | 4 | 50 | Europe | Gas and solvent for dispersion for injection/infusion, Conoxia | VU University Medical Center, ICaR-VU | During and after coronary artery bypass graft operation we will investigate the cardiovascular effects of hyperoxia on blood pressure, cardiac function, microcirculation and ischemia/reperfusion., We will study the effect of different amounts of oxygen during and immediately after cardiac surgery on blood pressure, the function of the heart and the small blood vessels, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
ChiCTR-IPR-14005470: Propofol Up-regulates MicroRNA-30b to repress Beclin-1 and Inhibits Excessive Autophagy and Apoptosis |
|
|
| Recruiting | 4 | 30 | | Propofol ;sevoflurane | Renminthe affiliated hospital of Guangdong medical college; the affiliated hospital of Guangdong medical college, the National Natural Science Foundation of China | ischemia reperfusion | | | | |
ChiCTR-TRC-14004766: Effect of dexmedetomidine postconditioning on renal protection in patients undergoing laparoscopic partial nephrectomy:a |
|
|
| Completed | 4 | 90 | | Injection of 0.9% saline ;Injection of 0.6ug/kg dexmedetomidine postconditioning | Second Affiliated Hospital of Anhui Medical University; Level of the institution:, National Natural Science Foundation of China, Project Grant NO.81200089 | Renal ischemia-reperfusion injury | | | | |
ChiCTR-IPR-14005399: Effects of sevoflurane on ischemia-reperfusion injury in living donor kidney transplantation |
|
|
| Recruiting | 4 | 75 | | none ;sevoflurane preconditioning ;sevoflurane postconditioning | the First Affiliated Hospital, College of Medicine, Zhejiang University; the First Affiliated Hospital, College of Medicine, Zhejiang University, the First Affiliated Hospital, College of Medicine, Zhejiang University | chronic renal failure | | | | |
2004-001862-42: A multicenter, double-blind, randomized 2x2 factorial design study to compare the efficacy of early (<6 hours) versus late (24-48 hours) ACE-inhibition and to compare the efficacy of Zofenopril and Lisinopril on oxidative reperfusion injury after a first acute anterior myocardial infarction: the ZAAMIS (Zofenopril After Acute Myocardial Infarction Study). |
|
|
| Ongoing | 4 | 30 | Europe | Zofenil, Zestril, PA0865, PA0970, Zofil (zofenopril), Zofil (zofenopril) | Clinical Research Facilities | Study population: Subjects undergoing a primary percutaneous coronary intervention (PCI) to be performed within 6 hours after the onset of symptoms of a first acute anterior myocardial infarction (MI). According to current standards of care, all subjects will have the PCI started less than 6 hours after the onset of the symptoms of AMI. | | | | |
2004-004983-56: A randomised placebo controlled trial of pre-operative statin use in elective abdominal aortic aneurysm repair to determine the effect on systemic and cellular responses of ischaemia reperfusion injury. |
|
|
| Ongoing | 4 | 40 | Europe | Atorvastatin 80mg, 756111000001109, Lipitor 80mg, Lipitor 80mg | Hull and East Yorkshire Hospitals NHS Trust, University of Hull | Ischaemia reperfusion injury following elective abdominal aortic aneurysm repair. This occurs when muscle or organ is subjected to an ischaemic insult with associated damage followed by reperfusion with the production of oxygen free radicals which further damage local and also distant tissues. This condition occurs in many conditions including myocardial infarction, peripheral vascular disease, and various medical procedures including repair of abdominal aortic aneurysm. | | | | |
2007-000151-33: Does caffeine reduce rosuvastatin-induced protection against ischemia-reperfusion injury? |
|
|
| Ongoing | 4 | 24 | Europe | Rosuvastatin, Crestor, Crestor | UMCN | Rosuvastatin is a proven cholesterol lowering medicine. Apart from it’s cholesterol lowering action, rosuvastatin may also increase tolerance against ischemia-reperfusion injury. We hypothesize that rosuvastatin increases tolerance against ischemia-reperfusion injury by induction of ecto-5’-nucleotidase and thereby increasing adenosine activity.This protective effect of rosuvastatin can be abbrogated by using the adenosine receptor antagonist caffeine. | | | | |
2007-005789-11: Does atorvastatin have an acute and prolonged inhibitory effect on ischemia-reperfusion injury in humans in-vivo? |
|
|
| Ongoing | 4 | 18 | Europe | atorvastatin, lipitor, lipitor | RUNMC | ischemia-reperfusion injury | | | | |
2008-004613-10: The role of the antioxidants ascorbic acid and n-acetylcysteine in the attenuation of ischaemia reperfusion injury in a human model |
|
|
| Ongoing | 4 | 90 | Europe | Parvolex, Rubex effervescent, Parvolex, Rubex effervescent, Parvolex | University College Hospital Galway | Ischaemia reperfusion injury | | | | |
2009-014831-18: Short term statin treatment and endothelial dysfunction due to ischemia and reperfusion injury |
|
|
| Ongoing | 4 | 48 | Europe | rosuvastatin, atorvastatin, rosuvastatin, lipitor, rosuvastatin, lipitor | RUNMC | ischemia and reperfusion injuryendothelial dysfunction | | | | |
2010-019713-21: A RANDOMISED CONTROLLED TRIAL TO COMPARE NORMOXIC VERSUS STANDARD CARDIOPULMONARY BYPASS IN CYANOTIC CHILDREN UNDERGOING CARDIAC SURGERY |
|
|
| Ongoing | 4 | 90 | Europe | OXYGEN (O2), N/A, Medical oxygen (Liquid), Medical oxygen (Liquid) | University Hospitals Bristol NHS Foundation Trust | The study investigates reoxygenation injury in cyanotic paediatric patients undergoing on-pump cardiac surgery. The types of heart condition being investigated result in chronic low blood oxygen saturation, causing cyanosis. | | | | |
ChiCTR-IPR-17011252: Protective effects of diffrent treatments of dexmedetomidine on lung injury induced by limb ischemia-reperfusion with tourniquet in elderly patients |
|
|
| Recruiting | 4 | 80 | | preconditioning ;postconditioning ;preconditioning united postconditioning ;not use dexmedetomidine during surgey | Wenzhou People's Hospital; Wenzhou People's Hospital, Wenzhou People's Hospital | lung injury | | | | |
ChiCTR1900021547: A randomized, double-blind, randomized controlled clinical trial of prophylactic corticosteroids on hepatic ischemia-reperfusion injury |
|
|
| Recruiting | 4 | 150 | | The use of hydrocortisone 100mg before interruption in operation, and intravenous drip of 100mg qd, 100mg qd, 50mg qd, common medicine 3 days after operation. ;Use of Methylprednisolone 80mg before interruption, and intravenous drip of 80mg qd, 80mg qd, 40mg qd, common medicine 3 days after operation. ;Use of normal saline 100ml before interruption, and intravenous drip of normal saline 100ml, common medicine 3 days after operation. | West China Hospital, Sichuan University; West China Hospital, Sichuan University, Graduate research funding | Ischemia-reperfusion of liver | | | | |
2019-000171-16: Comparison of the differences in the outcomes of patients receiving two different types of anaesthetics during heart surgery. |
|
|
| Not yet recruiting | 4 | 50 | Europe | Desflurane, Isoflurane, Sevoflurane, Propofol, Inhalation vapour, liquid, Emulsion for injection/infusion, Desflurane, Isoflurane, Sevoflurane, Diprivan | King's College Hospital NHS Foundation Trust, National Institute for Academic Anaesthesia | Cardiopulmonary bypass (CPB) and revascularisation-induced ischaemic reperfusion injury, Complications following Cardiopulmonary bypass (CPB) surgery, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03] | | | | |
ChiCTR1800018510: Compare the protective effects of dexmedetomidine and oxycodone in patients undergoing limb ischemia-reperfusion |
|
|
| Recruiting | 4 | 60 | | the control group received an equal amount of 0.9% saline ;prior to tourniquet inflation patients received a loading ;prior to tourniquet inflation patients received a bolus of oxycodone 0.05mg/kg (over 1 min) | The Third Hospital of HeBei Medical University; The Third Hospital of HeBei Medical University, This study was supported by grants from Natural Science Foundation of HeBei Province | ischemia-reperfusion injury | | | | |
ChiCTR1900021546: A prospective, double-blind, randomized controlled clinical trial for preventive use of ulinastatin on hepatic ischemia-reperfusion injury. |
|
|
| Recruiting | 4 | 712 | | Ulinastatin IV ;Normal Saline | West China Hospital, Sichuan University; West China Hospital, Sichuan University, 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University | Hepatic ischemia-reperfusion injury | | | | |
ChiCTR2000035274: Objective to explore the dose effect relationship of continuous sedation of rimazolom and its effect on ischemia-reperfusion after tourniquet in orthopedic surgery |
|
|
| Recruiting | 4 | 120 | | Different doses of remidazolam were pumped ;Effective dose of remidazolam was pumped ;Midazolam pump injection ;Pumping normal saline ;Midazolam was pumped | Shaoyang Central Hospital; Shaoyang Central Hospital, Jiangsu Hengrui Pharmaceutical Co., Ltd | Surgical sedation and ischemia reperfusion | | | | |
ChiCTR2100045801: Investigate the protective effects of dexmedetomidine in patients undergoing limb ischemia-reperfusion |
|
|
| Recruiting | 4 | 40 | | received an equal amount of 0.9% saline ;prior to tourniquet inflation patients received a loading dose of dexmedetomidine (0.8μg/kg over 10 min), followed by continuous infusion of dexmedetomidine (0.5 μg/kg/h)until end of the surgery | Tianjin Hospital; Tianjin hospital, self-raised | limb ischemia-reperfusion | | | | |
ChiCTR2100041840: Study of glutathione combine with vitamin C preconditioning to reduce hepatic ischemia-reperfusion injury after subtotal liver resection |
|
|
| Recruiting | 4 | 60 | | Pretreatment with glutathione and vitamin C ;Pretreatment with physiological saline | Taizhou People's Hospital; Taizhou People's Hospital, self fund | Hepatic ischemia reperfusion injury | | | | |
NCT06155110: A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI |
|
|
| Active, not recruiting | 4 | 160 | RoW | cardiomyopeptidin | Chinese PLA General Hospital, Dalian Zhen-Ao Bio-Tech Co., Ltd. | Cardiovascular Diseases | 03/24 | 05/24 | | |
ChiCTR2000031950: To investigate the effect of aromatherapy on reperfusion injury protection and long-term prognosis after STEMI intervention: a prospective, randomized controlled study |
|
|
| Recruiting | 4 | 270 | | Kuanxiong Aerosol ;placebo | Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM, Major Project of Yueyang Hospital | Acute myocardial infarction | | | | |
ChiCTR2000040680: A randomized controlled trial to assess the hepatoprotective effects of dexmedetomidine in pediatric living-donor liver transplantation recipients |
|
|
| Recruiting | 4 | 56 | | Dexmedetomidine preconditioning during pure laparoscopic donor hepatectomy ;Normal saline preconditioning during pure laparoscopic donor hepatectomy | Beijing Friendship Hospital, Capital Medical University; Capital Medical University affiliated Beijing Friendship Hospital, Department research funding | Hepatic ischemia reperfusion injury | | | | |
| Not yet recruiting | 4 | 90 | | Normal saline ;Dexmedetomidine continuous pumping ;Ulinastatin pretreatment dexmedetomidine continuous pumping | The First Affiliated Hospital of Bengbu Medical College; The First Affiliated Hospital of Bengbu Medical College, Bengbu Medical College Graduate Research and Innovation Project | Hepatic ischemia-reperfusion injury | | | | |
NCT05205304: The Role of Transdermal CO2 in MDA Level in Patient Underwent Abdominal Aortic Temporary Cross Clamp |
|
|
| Recruiting | 4 | 30 | RoW | D'Oxyva, Transdermal CO2 | Universitas Airlangga | Placenta Accreta | 12/22 | 12/22 | | |
ChiCTR2200060827: Efficacy of esketamine in lung protection after total knee replacement in elderly patients |
|
|
| Not yet recruiting | 4 | 90 | | Postoperative nerve block was given; Esticketamine was administered intraoperatively and postoperatively ;Esticketamine was given intraoperatively and postoperatively, and nerve block was given postoperatively | The Third Hospital of Hebei Medical University; The Third Hospital of Hebei Medical University, Hebei Provincial Science and Technology Plan project in 2021 | Total knee replacement | | | | |
| Recruiting | 4 | 20 | RoW | Pioglitazone 45 mg, pioglitazone hydrochloride | University of Campinas, Brazil | Myocardial Reperfusion Injury | 06/24 | 12/24 | | |
NCT05598177: Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass |
|
|
| Completed | 4 | 64 | RoW | dexmedetomidine, Placebo | Affiliated Hospital of Nantong University | Ischemia-Reperfusion Injury | 05/23 | 12/23 | | |
ChiCTR2200055170: Protective effect of Shenxiang Suhe Pill on myocardial ischemia-reperfusion injury and its mechanism |
|
|
| Recruiting | 4 | 60 | | none ;Shenxiang Suhe pill treatment ;none ;Shenxiang Suhe pill treatment | Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University; Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang Medical Association, Key Project of Clinical Research Fund (Special Project on Cardiovascular and Cerebrovascular Diseases), 2021ZYC-Z04 | Coronary atherosclerotic heart disease | | | | |
NCT05031026: Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfunction in Liver Transplantation |
|
|
| Active, not recruiting | 4 | 60 | RoW | Dexmedetomidine, Precedex, Normal Saline, NS 0.9% | Assiut University | Liver Transplant; Complications | 09/24 | 12/24 | | |
ChiCTR2300073266: To explore the effect and mechanism of edaravone dexborneol on acute cerebral ischemia-reperfusion injury via the miR-223-3p/NLRP3 pathway |
|
|
| Recruiting | 4 | 116 | | edaravone dexborneol ;conventional therapy | The First Affiliated Hospital of Chengdu Medical College; The First Affliated Hospital of Chengdu Medical College, Chinese Stroke Association | Acute ischemic stroke | | | | |
QSYQ for AMI, ChiCTR2300069035: Effects of Qishen Yiqi Dropping Pill on Ischemia-Reperfusion Injury and Myocardial Fibrosis in Patients with Acute Myocardial Infarction |
|
|
| Not yet recruiting | 4 | 90 | | Standard secondary preventive drug treatment+Qishen Yiqi drop pills 0.52g (1 bag) / time+placebo 0.52g (1 bag) / time, 3 times a day ;Standard secondary preventive drug treatment+Qishen Yiqi dropping pills 1.04g (2 bags) / time, 3 times a day ;Standard secondary preventive drug treatment+placebo 1.04g (2 bags) / time, 3 times a day | Peking University First Hospital; Peking University First Hospital, Tasly Pharmaceutical Group Co., Ltd. | Acute Myocardial Infarction | | | | |
ChiCTR2300075039: Mechanism of dexmedetomidine on lung injury induced by limb ischemia-reperfusion in replantation of severed fingers |
|
|
| Not yet recruiting | 4 | 98 | | Total intravenous general anesthesia ;Total intravenous general anesthesia added dexmedetomidine | the Third Affiliated Hospital of Guangxi Medical University; the Third Affiliated Hospital of Guangxi Medical University, Nanning Science and Technology Bureau | lung injury | | | | |
2008-008900-42: The DIEP flap as a model of ischemia-reperfusion: an intervention study |
|
|
| Ongoing | 3 | 30 | Europe | Zocor, fluimucil, RVG 13195, RVG 29806, Zocor, fluimucil, Zocor, fluimucil | MUMC | ischemia reperfusion | | | | |
2017-002514-32: XePOHCAS is a prospective, randomized, multicenter, interventional trial in adult subjects with OHCA during which the standard-of-care for post–cardiac arrest intensive care including TTM) is compared to the same treatment with the addition of 50% xenon by inhalation. |
|
|
| Ongoing | 3 | 1436 | Europe | XENEXâ„¢ (Xenon gas for inhalation), Medicinal gas, compressed | NeuroproteXeon, Inc., NeuroproteXeon, Inc. | Post-cardiac arrest syndrome, A syndrome including all clinical and biological manifestations related to the phenomenon of global ischemia-reperfusion triggered by cardiac arrest and return of spontaneous circulation., Diseases [C] - Nervous System Diseases [C10] | | | | |
NCT05708053: Cardio-protective Effect of Metformin in Patients Undergoing PCI |
|
|
| Active, not recruiting | 3 | 80 | RoW | Metformin | Future University in Egypt, Cairo University, Cairo University Hospitals | Elective Percutaneous Coronary Intervention, Ischemic Reperfusion Injury | 12/21 | 12/24 | | |
NCT05734612: The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury |
|
|
| Enrolling by invitation | 3 | 80 | RoW | Colchicine, Placebo (lactose) | Indonesia University | Reperfusion Injury, Myocardial | 03/23 | 03/23 | | |
NCT05327348: Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery |
|
|
| Recruiting | 3 | 34 | RoW | Intravenous Ascorbate, Ascorbic Acid Injection, Normal Saline 10 mL Injection, 0.9% Normal Saline | University of Malaya | Oxidative Stress, Ischemia-reperfusion Injury | 07/23 | 07/23 | | |
| Recruiting | 3 | 496 | RoW | Neu2000KWL group, Placebo group | GNT Pharma | Ischemic Stroke | 06/24 | 01/25 | | |
| Recruiting | 3 | 60 | Europe | Oxygen, feasibility of bubble and surface oxygenation applied to the LifePort Kidney Transporter (Organ Recovery Systems, Diegem, Belgium) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Delayed Graft Function, Kidney Transplant; Complications, Ischemia Reperfusion Injury, Mitochondrial | 01/25 | 01/26 | | |
ChiCTR2100051804: PINK1/Parkin pathway mediated mitochondrial autophagy in the effect and mechanism of dexmedetomidine on renal ischemia-reperfusion injury |
|
|
| Completed | 2/3 | 90 | | received intravenous infusion of Dexmedetomidine 1 Ug/kg 10 min after anesthesia induction, and then continued intravenous infusion at the rate of 0.4 ug/(kg h) until the end of operation ;0.9 % NS | The First Affiliated Hospital of Bengbu Medical College in Anhui Province; None, Department of Education, Anhui Province | Renal injury | | | | |
ACTRN12621000543886: Investigating the effect of melatonin on myocardial tissue when administered before cardiac surgery in adults. |
|
|
| Not yet recruiting | 2 | 114 | | | Sir Charles Gairdner Hospital, National Health and Medical Research Council | myocardial reperfusion injury, oxidative damage, inflammation | | | | |
2005-001525-28: INFLUENCE OF THE ANTIOXIDANT N-ACETYLCYSTEINE ON INHALED NITRIC OXIDE INDUCED PULMONARY RESPONSES FOLLOWING HUMAN LUNG ISCHAEMIA-REPERFUSION INJURY |
|
|
| Ongoing | 2 | 43 | Europe | INOmax® (nitric oxide), ACETYLCYSTEINE 200MG/ML INJECTION, | Imperial College London | heart-lung transplantation | | | | |
2006-006453-27: The use of epoetin beta in cardiac arrest victims: the impact on survival and neurological outcome |
|
|
| Ongoing | 2 | 200 | Europe | NeoRecormon, R02053859, NeoRecormon, NeoRecormon | Zdravstveni dom dr. Adolfa Drolca Maribor | The aim of our prospective, randomized, multicentered and controlled research is to determine the impact of erythropoietin on survival and neurological outcome of cardiac arrest victims. On the basis of previous research we expect that giving erythropoietin early in the course of cardiopulmonary resuscitation would decrease the ischaemic and reperfusion damage to the brain and heart after a period of cardiac arrest and thus it would improve neurological outcome of these patients. | | | | |
2010-022393-13: Does helium protect the heart against ischaemia-reperfusion damage in patients with acute myocardial infarction? |
|
|
| Ongoing | 2 | 70 | Europe | Heliox, Heliox | Academical Medical Center, University of Amsterdam | Acute myocardial infarction | | | | |
2010-019527-58: EMPIRE-Elafin Myocardial Protection from Ischaemia RepErfusion injury |
|
|
| Ongoing | 2 | 80 | Europe | Elafin, n/a, ELAFIN | NHS Lothian, University of Edinburgh | Myocardial ischaemia reperfusion injury Post-operative inflammation Post-ischaemic inflammatory injury | | | | |
2011-003572-36: The role of gut hormones replacement in improving blood flow to the brain after stroke that affects swallowing. |
|
|
| Ongoing | 2 | 40 | Europe | Liraglutide, Liraglutide, Liraglutide | Royal Devon & Exeter NHS Foundation Trust, University of Exeter, , University of Exeter | We plan to give a synthetic form of GLP-1 (Liraglutide) that is already available and licensed for use in patients with diabetes in the UK, to patients who have had an acute stroke, in order to determine whether increased levels protect the brain during its recovery, resulting in better recovery. | | | | |
2016-000623-73: LIDOCAINE IN ISCHEMIA-REPERFUSION INJURY FROM MICROSURGICAL BREAST RECONSTRUCTION. LIDOCAÍNA EN LA LESIÓN POR ISQUEMIA-REPERFUSIÓN EN RECONSTRUCCIÓN MAMARIA MICROQUIRÚRGICA. |
|
|
| Ongoing | 2 | 20 | Europe | Lidocaína B. Braun, Lidocaína B. Braun, Solution for injection, Lidocaína B. Braun | FUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL PUERTA DE HIERRO, FUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL PUERTA DE HIERRO | Ischemia-reperfusion injury from breast reconstruction microsurgical flaps. LESIÓN POR ISQUEMIA-REPERFUSIÓN DE LOS COLGAJOS MICROQUIRÚRGICOS DE RECONSTRUCCIÓN MAMARIA, Is the tissue damage caused by the reperfusion of blood supply to flap after a period ischemia, which creates a condition of inflammation and oxidative damage. Es el daño tisular causado por la reperfusión del colgajo después de un período de isquemia, que produce inflamación y daño oxidativo., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04] | | | | |
2014-002628-29: Ciclosporin to reduce damage to the heart during routine treatment for a heart attack (CAPRI) |
|
|
| Not yet recruiting | 2 | 68 | Europe | N/A, N/A, Concentrate for solution for infusion, Sandimmun (concentrate for solution for infusion 50mg/ml) | Newcastle upon Tyne Hospitals NHS Foundation Trust, NIHR Newcastle Biomedical Research Centre | Myocardial ischemia/reperfusion injury, Heart attack, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2017-001581-20: PREVENTION OF ISCHEMIA/REPERFUSION INJURIES IN LIVER TRANSPLANTATION RECIPIENTS BY ORAL ADMINISTRATION OF SIMVASTATIN INTO THE DECEASED BRAIN DONORS DURING THE HARVESTING PROCEDURES. PREVENZIONE DEL DANNO DA ISCHEMIA/RIPERFUSIONE AL PAZIENTE SOTTOPOSTO AL TRAPIANTO DI FEGATO MEDIANTE SOMMINISTRAZIONE DI SIMVASTATINA AL DONATORE CADAVERE NEL CORSO DELLE FASI DI PRELIEVO CHIRURGICO. |
|
|
| Not yet recruiting | 2 | 106 | Europe | SIMVASTATINA 40 mg capsule, SIMVA, Capsule, hard, SIMVASTATINA SANDOZ - 40 MG COMPRESSE RIVESTITE CON FILM 28 COMPRESSE IN BLISTER PVC/AL | ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE - ISMETT, MINISTERO DELLA SALUTE, RICERCA FINALIZZATA | ISCHEMIC REPERFUSION INJURY AFTER LIVER TRANSPLANTATION: HEPATIC ISCHEMIA AND REPERFUSION INJURY REPRESENTS THEMAIN UNDERLYING MECHANISM FOR GRAFT DYSFUNCTION, AND FAILURE, POST-TRANSPLANTATION. HYPOXIA AND REPERFUSIONACTIVATE INNATE MECHANISMS OF INFLAMMATION THAT CAUSES INJURY AND UNDERLINE DELAYED GRAFT FUNCTION. IT CAUSESALMOST 10% OF EARLY ORGAN FAILURE, AND CAN LEAD TO THE HIGHER INCIDENCE OF BOTH ACUTE AND CHRONIC REJECTION. DANNO DA ISCHEMIA RIPERFUSIONE DOPO TRAPIANTO DI FEGATO: LA SUA ESPRESSIONE CLINICA PU¿ ESSERE RAPPRESENTATADAL MANCATO FUNZIONAMENTO DELL¿ORGANO TRAPIANTATO, CHE PU¿ VERIFICARSI CON PICCHI DEL 10% DEI CASI. UNASINGOLA SOMMINISTRAZIONE DI SIMVASTATINA AL DONATORE CADAVERICO POTREBBE ESSERE PI¿ EFFICACE NEL MIGLIORARE ILMETABOLISMO DELL¿ORGANO TRAPIANTATO RISPETTO ALLA SOLA RIDUZIONE FISICA DI TEMPERATURA OTTENUTA CON LACONSERVAZIONE A FREDDO, HEPATIC ISCHEMIA & REPERFUSION INJURY AFFECTS HEPATIC CELLS THAT BECOME PROINFLAMMATORY INDUCING LIVER NECROSIS, INTRAHEPATIC CELLULAR INTERACTIONS & REPERFUSION INJURY CONTRIBUTE TO LIVER DYSFUNCTION I PRIMI 6 MESI DOPO IL TRAPIANTO DI FEGATO ¿CONSIDERATO IL PERIODO PI¿ VULNERABILE A CAUSA DI POTENZIALI ESITI DEL DANNO DA ISCHEMIA/RIPERFUSIONE (ES: LAMANCATA RIPRESA FUNZIONALE DOPO L¿INTERVENTO), Diseases [C] - Digestive System Diseases [C06] | | | | |
2012-001960-31: Combined drug approach to prevent liver injury during transplantation. Toediening geneesmiddelen om lever beschadiging tijdens transplantatie te verminderen. Réduction de dommage en transplantation hépatique après administration séquentielle de médicaments. |
|
|
| Not yet recruiting | 2 | 82 | Europe | Circadin, Flolan, Atenativ, NeoRecormon, Cetor, Vitamin E suspension, Apotransferrin, Remicade/Infliximab, Tationil 600, Cinryze, Prolonged-release tablet, Powder and solvent for solution for infusion, Solution for injection in pre-filled syringe, Powder and solvent for solution for injection, Oral suspension, Solution for infusion, Powder and solvent for concentrate for solution for infusion, Circadin, Flolan, Atenativ, NeoRecormon solution for injection in pre-filled syringe, Cetor 100E/ml poeder en oplosmiddel voor oplossing voor injectie, Vitamin E Suspension 100 mg/ml, Apotransferrin, Remicade, Tationil 600, Cinryze 500 eenheden poeder en oplosmiddel voor oplossing voor injectie | UZ Leuven, IWT-TBM | Investigation of the ischemia-reperfusion injury in patients who will undergo a liver transplantation after receiving a drug combination/multifactorial modulation beoordeling vermindering van de ischemie-reperfusie schade bij patiënten die een combinatie aan geneesmiddelen tijdens levertranplantatie hebben toegediend gekregen, Investigation of liver injury in patients who will undergo a liver transplantation after receiving a drug combination/multifactorial modulation beoordeling vermindering van leverschade bij patiënten die een een combinatie aan geneesmiddelen tijdens een levertransplantatie hebben toegediend gekregen, Body processes [G] - Biological Phenomena [G16] | | | | |
2021-006767-14: Alkaline phosphatase as a treatment to protect a kidney from hypoxia during tranplantation Alkalische fosfatase als behandeling om een nier te beschermen tegen zuurstoftekort tijdens transplantatie |
|
|
| Ongoing | 2 | 50 | Europe | bovine Rescue Alkaline Phosphatase, Infusion | Amsterdam UMC, Alloksys life sciences B.V., Health Holland B.V. | ischemia reperfusion injury in kidneys transplanted from donors after cardiac death ischemie reperfusieschade in getransplanteerde nieren van overleden donoren na hartdood, hypoxic damage in transplanted kidneys from deceased donors nierschade door zuurstoftekort tijdens transplantatie nadat donor overleden is, Body processes [G] - Immune system processes [G12] | | | | |
| Active, not recruiting | 2 | 228 | RoW | Cangrelor, Kengreal | National Heart Centre Singapore, Tan Tock Seng Hospital, National University Hospital, Singapore, Khoo Teck Puat Hospital, Changi General Hospital, Sengkang General Hospital | STEMI | 12/22 | 12/22 | | |
CINERGY, NCT05148715: Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function |
|
|
| Recruiting | 2 | 414 | Canada | Tacrolimus, Prograf, Placebo | Université de Sherbrooke, McMaster University | Organ Transplant Failure or Rejection, Brain Death, Ischemic Reperfusion Injury | 01/25 | 01/26 | | |
| Completed | 2 | 5 | Europe | Ciclosporin A preconditioning before renal artery stenosis dilation, NaCl preconditioning before renal artery stenosis dilation | Hospices Civils de Lyon | Renal Artery Stenosis | 06/20 | 06/20 | | |
PULSE-MI, NCT05462730: Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction |
|
|
| Active, not recruiting | 2 | 530 | Europe | Methylprednisolone, Solu-Medrol, Isotonic saline, Isotonic NaCl, Placebo | Thomas Engstrom | ST Elevation Myocardial Infarction, Inflammatory Response, Myocardial Reperfusion Injury, Myocardial Injury | 01/24 | 10/24 | | |
| Not yet recruiting | 2 | 125 | NA | Sodium Lactate Solution, Hyperonic sodium lactate | Erasme University Hospital | Cardiac Arrest, Ischemia Reperfusion Injury, Anoxic Brain Injury | 12/25 | 05/26 | | |
| Recruiting | 2 | 304 | US | Niacinamide, Placebo | Kaiser Permanente, National Heart, Lung, and Blood Institute (NHLBI), Beth Israel Deaconess Medical Center, Cedars-Sinai Medical Center | Ischemia Reperfusion Injury, Myocardial Injury, Acute Kidney Injury | 04/25 | 06/25 | | |
| Not yet recruiting | 1/2 | 200 | | | Te Whatu Ora Waikato, Te Whatu Ora Waikato | ST-Elevation Myocardial Infarction | | | | |
| Active, not recruiting | 1/2 | 45 | US | Berinert, C1 Esterase Inhibitor (C1INH), Placebo, Normal Saline | Cedars-Sinai Medical Center, OneLegacy Foundation | End Stage Renal Disease, Chronic Kidney Diseases | 07/22 | 03/24 | | |
NCT05246618: FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation |
|
|
| Completed | 1/2 | 18 | Europe | TUM012, Ex-vivo infusion, Placebo | iCoat Medical AB, CTC Clinical Trial Consultants AB, Region Skane | Ischemia-reperfusion Injury, Kidney Transplant; Complications | 07/23 | 05/24 | | |
NCT03533153: Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction |
|
|
| Not yet recruiting | 1/2 | 90 | NA | WJ-MSC cells implantation, WJ-MSC, CTSTMD PBS without WJ-MSC, CTSTMD PBS, Conventional drug therapy, Conventional | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Myocardial Infarction | 12/23 | 12/25 | | |
| Recruiting | 1/2 | 20 | RoW | Mechanical thrombectomy combined with ischemic post-conditioning | Capital Medical University | Acute Ischemic Stroke, Reperfusion Injury | 12/23 | 03/24 | | |
| Active, not recruiting | 1/2 | 30 | US | Conjugated Estrogen, Premarin, Normal saline, 0.9% sodium chloride | University of Pennsylvania | Ischemia Reperfusion Injury | 01/25 | 01/25 | | |
NCT04005469: Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation |
|
|
| Recruiting | 1/2 | 20 | US | Treprostinil, Remodulin® | Rhode Island Hospital, University of Rhode Island, United Therapeutics | Ischemia Reperfusion Injury, Delayed Graft Function | 07/25 | 06/26 | | |
ACTRN12615000678594: Mesenchymal Stem Cells (MSC) for the amelioration of ischaemia-reperfusion injury (IRI) after deceased donor renal transplantation, a phase 1 pilot study |
|
|
| Recruiting | 1 | 10 | | | Royal Perth Hospital, Transplant Society of Australia and New Zealand (TSANZ)-AMGEN 2013 Innovation Grant | Ischaemia reperfusion injury, Kidney Transplantation | | | | |
ChiCTR-TRC-08000129: the effect of ischemia/reperfusion injuries by pringle manoeuvre on the prognosis of hepatocellular carcinoma patients after radical excision |
|
|
| Completed | 1 | 200 | | Liver cancer radical cure by ischemia injuries by ;Liver cancer radical cure treatment by pringle manoeuvre. | Institute of Hepatobiliary Surgery, Southwest Hospital; Level of the institution:, Self-funded | Heptitis virus B related primary hepatocellular carcinoma | | | | |
NCT05215743: Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study. |
|
|
| Completed | 1 | 18 | RoW | Antioxidant therapy, ascorbate, n-acetylcysteine, deferoxamine, NaCl 0.9%, saline solution | University of Chile, Fondo Nacional de Desarrollo Científico y Tecnológico, Chile | Acute Myocardial Infarction, Ischemia-reperfusion Injury, Reperfusion Injury, Myocardial, Reperfusion Arrhythmias, Reperfusion Injury | 11/22 | 12/22 | | |
NCT05217654: Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction |
|
|
| Recruiting | 1 | 32 | Europe | Dapagliflozin 10mg, Forxiga 10mg Tabletten, Placebo, Placebo tablets | Medical University of Vienna | Reperfusion Injury, Vascular Complications | 02/23 | 08/23 | | |
ChiCTR2200057444: The mechanism of TGF-β1-induced TRPV1 sensitization in myocardial ischemia-reperfusion injury |
|
|
| Not yet recruiting | 1 | | | | The first affiliated hospital of USTC Anhui provincial hospital; The first affiliated hospital of USTC Anhui provincial hospital, self-financing | Myocardial Ischemia Reperfusion Injury | | | | |
NCT04388761: Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI) |
|
|
| Withdrawn | 1 | 15 | NA | Allogeneic adipose derived mesenchymal stem cells | Tambi Jarmi | Ischemia Reperfusion Injury | 02/24 | 02/24 | | |
NCT06097702: A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants |
|
|
| Recruiting | 1 | 64 | RoW | BX-001N Part 1, BX-001N Part 2, Placebo | Bilix Co.,Ltd. | Ischemia-reperfusion Injury | 04/24 | 06/24 | | |
NCT06369350: Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion |
|
|
| Not yet recruiting | 1 | 30 | NA | Vitamin B6 25 MG, Vitamin B6 50 MG, Vitamin B6 100 MG, Placebo | Milton S. Hershey Medical Center, American Heart Association | Ischemia Reperfusion Injury, Peripheral Artery Disease | 09/25 | 09/25 | | |
NCT01481974: Safety and Efficacy of Treprostinil in Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplantation |
|
|
| Completed | 1 | 35 | US | Treprostinil, Brand name: REMODULIN | Abhinav Humar, MD | Ischemia Reperfusion Injury | 05/19 | 11/19 | | |
| Recruiting | 1 | 53 | US | Hydrogen, H2 gas, Usual care, Standard of care | Boston Children's Hospital, Baylor College of Medicine | Cardiac Arrest, Extracorporeal Membrane Oxygenation, Reperfusion Injury | 03/27 | 08/27 | | |
ACTRN12623000301662: Marine oxygen carrier (M101) for organ preservation in liver transplantation; a randomised exploratory study. |
|
|
| Not yet recruiting | N/A | 20 | | | A/Prof Louise Barbier | Liver Transplantation | | | | |
ChiCTR2100050204: Effect of remote ischemic treatment combined with auricular vagus nerve stimulation on reperfusion injury in acute myocardial infarction and its long-term outcome |
|
|
| Not yet recruiting | N/A | 201 | | In the TVNS group, an electronic stimulator was applied for low-frequency square pulse stimulation (20 Hz, pulse width 1 ms) at the tragus of the right ear, and the current intensity was gradually increased until a slowing of the sinus rate occurred ;Simultaneous intermittent use of sphygmomanometer cuff for pressurized inflation to 200 mmHg in the left upper arm for 5 minutes after admission and during coronary angiography in the catheterization room causes limb ischemia followed by deflation. The process is divided into 4 cycles, with an interval of 5 ;Routine PCI without additional treatment | Quanzhou First Hospital; Quanzhou First Hospital, Apply for funding from the Science and Technology Bureau | acute myocardial infarction | | | | |
| Completed | N/A | 60 | | venous continous infusion intralipid ;venuous continuous infusion alprostadil | Cancer Center, Sun Yat-sen University; Cancer Center, Sun Yat-sen University, self-financing | renal carcinoma | | | | |
ChiCTR-TRC-12002111: The influence of limb ischemia reperfusion on remote organs in aged population undergoing articular genu replacement and potential protective methods |
|
|
| Completed | N/A | 75 | | without intervention ;Ischemia-reperfusion preconditioning ;intravenous infusion of Dexmedetomiding ;Intravenous infusion of Ulinastatin ;Intravenous infusion of Ulinastatin | Southwest Hospital, Third Military Medical University; Level of the institution:, Hospital Clinic Research Grant | Ischemia Reperfusion Injury | | | | |
ChiCTR-TRC-14004422: Effect of biocoen for tourniquet-induced ischemia-reperfusion injury on knee Arthroscopy |
|
|
| Completed | N/A | 30 | | biocoen 0.05U/kg ;biocoen 0.05U/kg | Anesthesiology Department, Zhongnan hospital, Wuhan University; Level of the institution:, Instructor funding | NA | | | | |
ChiCTR-ICR-14005495: The protective effect of hydrogen gas against myocardial ischemia-reperfusion injury in patient undergoing coronary artery bypass surgery with cardiopulmonary bypass |
|
|
| Not yet recruiting | N/A | 60 | | 80% oxygen is supplied to the blood by cardiopulmonary bypass machine during CPB ;the combination of 2% hydrogen gas and 80% oxygen is supplied to the blood by cardiopulmonary bypass machine for 1 hour and then only 80% oxygen is supplied during CPB | Tianjin Medical University General Hospital; Tianjin Medical University General Hospital, self-funded | coronary arteriosclerotic heart disease | | | | |
ChiCTR1800015393: Clinical study on protective effect of limb ischemic preconditioning on lung ischemia-reperfusion injury |
|
|
| Completed | N/A | 241 | | non-invasive limb ischemic preconditioning ;Routine treatment | Xiuling Jin; The First Affiliated Hospital of Wenzhou Medical University, N/A | myocardial injury occurred under cardiac bypass surgery | | | | |
ChiCTR-ICC-15007000: Protective effect of propofol pretreatment on myocardial ischemic reperfusion injury during CPB |
|
|
| Recruiting | N/A | 60 | | Combination of propofol and Sevoflurane ;Sevoflurane | Affiliated Hospital of Guangdong Medical College; Affiliated Hospital of Guangdong Medical College, 2012 National Natural Science Fund: Propofol postconditioning allevate endothelial injury inducede by ischemia-reperfusion via balancing Ang1-7/AngⅡ | myocardial ischemic reperfusion injury | | | | |
ChiCTR-INR-17010499: The effect of transcutaneous electrical acupoint stimulation on the inflammatory response in patients undergoing limb ischemia-reperfusion |
|
|
| Recruiting | N/A | 40 | | Transcutaneous Electrical Acupoint Maxium stimulation ;Transcutaneous Electrical Acupoint minimum stimulation | The First Affiliated Hospital of Wenzhou Medical University; The first affiliated hospital of Wenzhou medical university, National Natural Science Foundation of China (Grant81603685, 81273926, 81573742), Zhejiang Province Natural Science Foundation (Grant LY15H270014, LY15H2900 | lung injury | | | | |
ChiCTR-RNC-17011481: MicroRNAs involve in the Act1/IL-17RA mediation mechanism in cerebral ischemia reperfusion |
|
|
| Recruiting | N/A | 50 | | Nil | First Affiliated Hospital, Harbin Medical University; First Affiliated Hospital, Harbin Medical University, the National Natural Science Foundation of China | Ischemic stroke | | | | |
ChiCTR-ROC-16008339: The mechanism of bidirectional regulation of acupuncture and moxibustion on Jak2-Stat3 pathway in cerebral ischemia reperfusion injury |
|
|
| Not yet recruiting | N/A | 40 | | Acupuncture ;No acupuncture | The First Affiliated Hospital of Wenzhou Medical University; the First Affiliated Hospital of Wenzhou Medical University, topic | Cerebral ischemia reperfusion injury | | | | |
ChiCTR-INR-17014208: A Clinical Study of Enhancement of fracture healing by Transient Ischemia-reperfusion treatment |
|
|
| Recruiting | N/A | 200 | | Treatment of repeated ischeia-reperfusion after operation. ;Without RII treatment | Capital Medical University affiliated Beijing Chaoyang Hospital; Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Municipal Science& Technology Commission | Limb fracture | | | | |
ChiCTR-INR-16009711: Effect of penehyclidine hydrochloride on myocardial ischemia reperfusion injury in patients undergoing off-pump coronary aortic bypass grafting |
|
|
| Recruiting | N/A | 120 | | 5ml 9% NaCl ;PHC10ug/kg ;PHC 30ug/kg ;PHC 50ug/kg | Beijing Anzhen Hospital; Beijing Anzhen Hospital, Capital Medical University | coronary artery disease | | | | |
ChiCTR-INR-17011224: Ringerfundin in perioperative clinical application research of liver ischemia/reperfusion protection |
|
|
| Recruiting | N/A | 40 | | Salinger acetate solution15ml/kg ;Malic acid acetic acid fluid of salinger15ml/kg | Shanghai Changzheng Hospital; Shanghai Changzheng Hospital, None | Liver resection Anesthesia | | | | |
ChiCTR-PRC-17012215: Protective strategy on multi-organs ischemia-reperfusion injury caused by renal transplantation during perioperative period |
|
|
| Not yet recruiting | N/A | 400 | | creatine phosphate sodium therapy ;saline solution therapy | Anhui Provincial Hospital (the Affiliated Provincial Hospital of Anhui Medical University); Anhui Provincial Hospital, Application research of Anhui Provincial public welfare technology on linkage projects | end-stage renal disease | | | | |
ChiCTR-POR-15007274: Effect of electro-acupuncture of jiaji-acupoints on spinal cord ischemia-reperfusion injury after cervical decompression surgery in patients with cervical spondylotic myelopathy: a randomized controlled trial |
|
|
| Not yet recruiting | N/A | 60 | | electro-acupuncture of jiaji-acupoints ;none electro-acupuncture of jiaji-acupoints | Shaoxing Hospital of TCM affiliated to Zhejiang Chinese Medical University; Shaoxing Hospital of TCM affiliated to Zhejiang Chinese Medical University, self-financing | Cervical Spondylotic Myelopathy | | | | |
ChiCTR1800016840: Effect of remote ischaemic preconditioning on hepatic ischemia-reperfusion injury |
|
|
| Recruiting | N/A | 120 | | ischemic preconditioning on right arm ;10-min liver ischemia and 10-min ischemia reperfusion by the first porta hepatis before liver resection ;a deflated cuff placed on the right upper arm for 30 min after anesthesia induction before surgery | Shanghai Eastern Hepatobiliary Surgery Hospital; Shanghai Eastern Hepatobiliary Surgery Hospital, Department of Anesthesiology, Shanghai Eastern Hepatobiliary Surgery Hospital | Hepatic ischemia-reperfusion injury | | | | |
| Active, not recruiting | N/A | 2613 | Europe, RoW | Remote Ischaemic Conditioning (RIC) | Aarhus University Hospital, Rigshospitalet, Denmark, Aalborg Universitetshospital, Odense University Hospital, Hospital Universitario Central de Asturias, Clinical Centre of Serbia, Military Medical Academy, Belgrade, Serbia, The Hatter Cardiovascular Institute, London W, United Kingdom, Central Denmark Region, Region of Southern Denmark, Prehospital Emergency Medical Service, The North Denmark Region, Region Zealand, The Danish Medical Research Council | Myocardial Reperfusion Injury | 03/19 | 09/19 | | |
ChiCTR1800016797: The mechamism and effect of cardiac stem cell-derived μ opioid receptor mediated protection by morphine preconditioning on the failing heart against post-ischemia reperfusion injury via Caveolin-3/MG53 signal pathway |
|
|
| Not yet recruiting | N/A | 20 | | No | The Second Hospital of Anhui Medical University; The Second Hospital of Anhui Medical University, The Research foundation of Anhui Medical University | chronic heart failure | | | | |
ChiCTR2000032546: The role of macrophage extracellular traps in hepatic ischemia reperfusion injury |
|
|
| Completed | N/A | 50 | | NA | the Third Affiliated Hospital of Sun Yat-sen University; the Third Affiliated Hospital of Sun Yat-sen University, National Natural Science Foundation of China | liver disease | | | | |
ChiCTR1800017341: Protective Effects of Enhanced External Counterpulsation on Myocardial Ischemia Reperfusion, Microvascular Dysfunction and Heart Function in Patients With ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention |
|
|
| Not yet recruiting | N/A | 104 | | PCI+enhanced external counterpulsation ;PCI | JiangMen Central Hospital; JiangMen Central Hospital, non | myocardial infarction | | | | |
ChiCTR2000040803: Relationship between serum mir-21 and mir-126 levels and reperfusion injury in patients with acute myocardial infarction |
|
|
| Completed | N/A | | | | Shanxi Bethune Hospital; Shanxi Bethune Hospital, The Shanxi Science and Technology Department | Acute Myocardial Infarction | | | | |